IDH1/2

Paresh Vyas | ISAL 2019 | Clonal evolution under IDH inhibitor treatment in patients with AML

L:

ACUTE LEUKEMIAS XVII Biology and Treatment Strategies, February 24-27 2019, Munich, DE

Paresh Vyas University of Oxford, Oxford, UK

Interview Topic: Clonal evolution under IDH inhibitor treatment in patients with AML

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF